Marios Fotiadis is a Managing Director at Enterprise Partners in the Life Sciences practice.
Mr. Fotiadis joined Enterprise Partners from Advent International where he worked with the Life Sciences Venture team. Prior to Advent International, Marios was CEO of Achillion Pharmaceuticals (Nasdaq: ACHN), a biotechnology company focused on the development of novel treatments for infectious diseases.
Before joining Achillion, Marios managed the life sciences venture portfolio of SG Capital Partners, a $550 million private equity fund with more than $8
View Full Bio